Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BioStem Technologies

Explore full profile

BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies

Pompano Beach, United StatesFounded 2006Biotech & Life Sciences
Valuation $84M Market cap · 2026
Revenue $47M Latest reported FY
EBITDA $31M Latest reported FY

About BioStem Technologies

BioStem Technologies is a regenerative medicine company that develops, manufactures, and commercializes placental-derived allografts for advanced wound care applications.

The company's business model is centered around the development and commercialization of regenerative therapies derived from perinatal tissues. BioStem Technologies operates in the advanced wound care market, a sector of the broader healthcare industry. Its product portfolio includes brands such as RHEO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC, which are designed to provide solutions for complex wounds.

The company serves a range of clients within the healthcare system, including hospitals, clinics, and other healthcare facilities that require advanced wound care treatments. As a publicly traded entity on the OTC markets (BSEM), BioStem Technologies is also focused on creating value for its shareholders through the advancement of its product pipeline and commercial activities.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2006
Headquarters
Pompano Beach, United States
Listing
IPO 2008
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States97.6%
🇵🇭 Philippines2.4%
2 countries shown
Web traffic by country
4.8K monthly visits
across markets
🇺🇸 United States68.8%
🇮🇳 India6.3%
Top 2 markets shown

Patents

Estimated portfolio value
$4M

16 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BioStem Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BioStem Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.